Aike Li
Aike Li has a total of 71 co-authors. Here are the top co-authors by number of shared publications:
- Weiwei Wang
Key Laboratory of Grain and Oil Biotechnology, Academy of National Food and Strategic Reserves Administration, Beijing, 100037, China
13 shared publications - Beibei He
Academy of National Food and Strategic Reserves Administration, Beijing 100037, China
9 shared publications - Yongwei Wang
Key Laboratory of Grain and Oil Biotechnology, Academy of National Food and Strategic Reserves Administration, Beijing 100037, China
8 shared publications - Jingjing Shi
Academy of National Food and Strategic Reserves Administration, Beijing 100037, China
7 shared publications - Li Wang
Academy of National Food and Strategic Reserves Administration, Beijing 100037, China
7 shared publications - Kuanbo Liu
Key Laboratory of Grain and Oil Biotechnology, Academy of National Food and Strategic Reserves Administration, Beijing 100037, China
6 shared publications
Latest Publications
- 18 July 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 255, 319-332
Lactiplantibacillus plantarum LP15-1 regulates intestinal innate immunity via suppressing the NF-κB pathway to modulate M cell differentiation
- 18 July 2026
- Published by Elsevier in Free Radical Biology and Medicine
- Vol. 255, 319-332
Lactiplantibacillus plantarum LP15-1 regulates intestinal innate immunity via suppressing the NF-κB pathway to modulate M cell differentiation
- Open Access
- 3 July 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (7)
Optimizing Broiler Diets: Nutritional and Functional Benefits of Fermented Cottonseed Meal
Cottonseed meal (CSM) contains antinutritional factors limiting its use. Fermentation may improve its nutritional value. This study examined the nutritional properties of fermented cottonseed meal (FCSM) and its effects on broilers. The nutritional composition of fermented CSM and FCSM was analyzed. Subsequently, 175 AA broilers were randomly assigned to five dietary treatments: a basal control diet (CON), and diets containing 6% CSM, 6% FCSM, 9% FCSM, or 12% FCSM. Fermentation significantly increased crude protein, acid‐soluble protein, L ‐lactic acid, and gross energy of CSM ( p < 0.05), while decreasing free gossypol and crude fiber content ( p < 0.05). FCSM also significantly enhanced the standardized ileal digestibility of glutamate and valine ( p < 0.05), but not other amino acids. In broilers, dietary inclusion of 9% FCSM increased body weight and average daily gain during the starter phase compared to the 6% CSM diet ( p < 0.05). At day 21, both 6% and 9% FCSM diets significantly increased serum concentrations of IgA, IgG, and IgM compared to the CON group ( p < 0.05). The 6% FCSM group demonstrated a significant enhancement in the villus height to crypt depth ratio compared to the 6% CSM diet ( p < 0.05). Additionally, 6% FCSM significantly raised cecal concentrations of acetate, propionate, butyrate, and total short‐chain fatty acids at 21 days ( p < 0.05). In conclusion, fermentation enhances the nutritional profile of CSM by improving protein utilization and reducing antinutritional factors. Dietary inclusion of 6%–9% FCSM improves starter‐phase growth performance, immune function, and intestinal health in broilers.
- 3 July 2026
- Published by Wiley in Food Science & Nutrition
- Vol. 14 (7)
Open AccessOptimizing Broiler Diets: Nutritional and Functional Benefits of Fermented Cottonseed Meal
Cottonseed meal (CSM) contains antinutritional factors limiting its use. Fermentation may improve its nutritional value. This study examined the nutritional properties of fermented cottonseed meal (FCSM) and its effects on broilers. The nutritional composition of fermented CSM and FCSM was analyzed. Subsequently, 175 AA broilers were randomly assigned to five dietary treatments: a basal control diet (CON), and diets containing 6% CSM, 6% FCSM, 9% FCSM, or 12% FCSM. Fermentation significantly increased crude protein, acid‐soluble protein, L ‐lactic acid, and gross energy of CSM ( p < 0.05), while decreasing free gossypol and crude fiber content ( p < 0.05). FCSM also significantly enhanced the standardized ileal digestibility of glutamate and valine ( p < 0.05), but not other amino acids. In broilers, dietary inclusion of 9% FCSM increased body weight and average daily gain during the starter phase compared to the 6% CSM diet ( p < 0.05). At day 21, both 6% and 9% FCSM diets significantly increased serum concentrations of IgA, IgG, and IgM compared to the CON group ( p < 0.05). The 6% FCSM group demonstrated a significant enhancement in the villus height to crypt depth ratio compared to the 6% CSM diet ( p < 0.05). Additionally, 6% FCSM significantly raised cecal concentrations of acetate, propionate, butyrate, and total short‐chain fatty acids at 21 days ( p < 0.05). In conclusion, fermentation enhances the nutritional profile of CSM by improving protein utilization and reducing antinutritional factors. Dietary inclusion of 6%–9% FCSM improves starter‐phase growth performance, immune function, and intestinal health in broilers.
- Open Access
A Novel Genetic Engineering Approach for DON Detoxification Using a Yeast-Based Multi-Enzyme System
Deoxynivalenol (DON), a Group III carcinogenic mycotoxin frequently detected in cereals and animal-derived food products, poses serious health risks to animals and humans. In this study, we developed a genetically engineered Saccharomyces cerevisiae strain as a proof-of-concept platform for DON detoxification. The yeast was engineered to co-express two detoxification genes, YTDepA and YTDepB (homologs of DepA and DepB from Devosia mutans 17-2-E-8) originally identified in Youhaiella tibetensis. Concurrently, the pyrroloquinoline quinone (PQQ) biosynthesis gene cluster from Klebsiella pneumoniae was integrated to supply the essential cofactor. Gene expression was verified by qRT-PCR and Western blot. The recombinant strain demonstrated a significant 13.98% detoxification of DON after 72 h of fermentation (p < 0.05), as confirmed by HPLC–MS, while the strain expressing only the PQQ cluster showed no detoxification activity. This study establishes an integrated yeast cell factory for DON detoxification and highlights key limitations to guide future optimization efforts.
Open AccessA Novel Genetic Engineering Approach for DON Detoxification Using a Yeast-Based Multi-Enzyme System
Deoxynivalenol (DON), a Group III carcinogenic mycotoxin frequently detected in cereals and animal-derived food products, poses serious health risks to animals and humans. In this study, we developed a genetically engineered Saccharomyces cerevisiae strain as a proof-of-concept platform for DON detoxification. The yeast was engineered to co-express two detoxification genes, YTDepA and YTDepB (homologs of DepA and DepB from Devosia mutans 17-2-E-8) originally identified in Youhaiella tibetensis. Concurrently, the pyrroloquinoline quinone (PQQ) biosynthesis gene cluster from Klebsiella pneumoniae was integrated to supply the essential cofactor. Gene expression was verified by qRT-PCR and Western blot. The recombinant strain demonstrated a significant 13.98% detoxification of DON after 72 h of fermentation (p < 0.05), as confirmed by HPLC–MS, while the strain expressing only the PQQ cluster showed no detoxification activity. This study establishes an integrated yeast cell factory for DON detoxification and highlights key limitations to guide future optimization efforts.
- Open Access
- 25 December 2025
- Published by MDPI AG in Fermentation
- Vol. 12 (1) , 13
Upcycling of Chinese Nong-Flavor Baijiu Distiller’s Grains Through Solid-State Fermentation by Microbial-Enzyme Synergy
Chinese Baijiu distiller’s grains are by-products of the Chinese Baijiu brewing process, characterized by high water content, high acidity, and high fiber content, which make them unsuitable for animal feed, especially for monogastric animals. This study investigated the possibility of increasing the feed value of Nong-flavor Baijiu distiller’s grains (NFBDGs) for monogastric animals via solid-state fermentation by microbial-enzyme synergy. Experiments evaluated microbial growth, pH variation, improvement of crude protein (CP), true protein (TP), and acid-soluble protein (ASP), degradation of crude fiber (CF), acid detergent fiber (ADF), and neutral detergent fiber (NDF). The results indicated that Ligilactobacillus salivarius CRS23, Bacillus subtilis YLZ7, Saccharomyces cerevisiae CJM26, and xylanase were identified for the fermentation of NFBDGs. When the initial moisture content of NFBDGs was 60% and the initial pH was 3.4, under the conditions of aerobic fermentation at 37 °C for 4 days, the pH of NFBDGs increased from 3.49 to 6.04, the contents of CP and TP increased by 33.59% and 31.21%,,, respectively, while the contents of CF, ADF, and NDF decrease by 35.44%, 20.53%, and 25.02% respectively. The nutritional value of NFBDGs was significantly improved after microbial-enzyme synergistic fermentation, providing a new approach for their application as feed.
- 25 December 2025
- Published by MDPI AG in Fermentation
- Vol. 12 (1) , 13
Open AccessUpcycling of Chinese Nong-Flavor Baijiu Distiller’s Grains Through Solid-State Fermentation by Microbial-Enzyme Synergy
Chinese Baijiu distiller’s grains are by-products of the Chinese Baijiu brewing process, characterized by high water content, high acidity, and high fiber content, which make them unsuitable for animal feed, especially for monogastric animals. This study investigated the possibility of increasing the feed value of Nong-flavor Baijiu distiller’s grains (NFBDGs) for monogastric animals via solid-state fermentation by microbial-enzyme synergy. Experiments evaluated microbial growth, pH variation, improvement of crude protein (CP), true protein (TP), and acid-soluble protein (ASP), degradation of crude fiber (CF), acid detergent fiber (ADF), and neutral detergent fiber (NDF). The results indicated that Ligilactobacillus salivarius CRS23, Bacillus subtilis YLZ7, Saccharomyces cerevisiae CJM26, and xylanase were identified for the fermentation of NFBDGs. When the initial moisture content of NFBDGs was 60% and the initial pH was 3.4, under the conditions of aerobic fermentation at 37 °C for 4 days, the pH of NFBDGs increased from 3.49 to 6.04, the contents of CP and TP increased by 33.59% and 31.21%,,, respectively, while the contents of CF, ADF, and NDF decrease by 35.44%, 20.53%, and 25.02% respectively. The nutritional value of NFBDGs was significantly improved after microbial-enzyme synergistic fermentation, providing a new approach for their application as feed.
- Open Access
- 21 July 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (14) , 7025
Lipid Oxidation of Stored Brown Rice Changes Ileum Digestive and Metabolic Characteristics of Broiler Chickens
Long-term storage may induce lipid oxidation in brown rice and impact its utilization in animal diets. One-day-old male Ross 308 broiler chickens (with an initial body weight of 20 g) were randomly divided into three groups: corn-based diet (Corn), fresh brown rice-based diet (BR1) and stored brown rice-based diet (BR6), with 8 replicates of 10 birds per pen, in a 42-day feeding trial. The results showed that lipid oxidation indexes increased and fatty acid composition changed significantly in BR6 (p < 0.05). The dietary replacement of corn with brown rice showed no effects on growth performance of broilers (p > 0.05). However, palmitic acid and oleic acid increased, and stearic acid, linoleic acid and docosadienoic acid decreased in the broiler breast muscle of the BR1 and BR6 groups (p < 0.05). Ileum antioxidant enzyme activities increased in the BR1 and BR6 groups compared to the Corn group (p < 0.05), and the activities of α-amylase, trypsin, chymotrypsin and lipase decreased in the BR6 group compared to the BR1 and Corn groups (p < 0.05). Also, compared to the BR1 group, the overall expression of metabolites involved in drug metabolism—cytochrome P450, GnRH secretion and the estrogen signaling pathway in broiler ileum were down-regulated in the BR6 group (p < 0.05). In conclusion, the lipid oxidation of stored brown rice decreased digestive enzyme activities and changed metabolic characteristics in the ileum of broilers. While replacing corn with brown rice did not affect broiler growth performance, it reduced the contents of unsaturated and essential fatty acids in breast muscle and enhanced the ileal antioxidant functions of broilers.
- 21 July 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (14) , 7025
Open AccessLipid Oxidation of Stored Brown Rice Changes Ileum Digestive and Metabolic Characteristics of Broiler Chickens
Long-term storage may induce lipid oxidation in brown rice and impact its utilization in animal diets. One-day-old male Ross 308 broiler chickens (with an initial body weight of 20 g) were randomly divided into three groups: corn-based diet (Corn), fresh brown rice-based diet (BR1) and stored brown rice-based diet (BR6), with 8 replicates of 10 birds per pen, in a 42-day feeding trial. The results showed that lipid oxidation indexes increased and fatty acid composition changed significantly in BR6 (p < 0.05). The dietary replacement of corn with brown rice showed no effects on growth performance of broilers (p > 0.05). However, palmitic acid and oleic acid increased, and stearic acid, linoleic acid and docosadienoic acid decreased in the broiler breast muscle of the BR1 and BR6 groups (p < 0.05). Ileum antioxidant enzyme activities increased in the BR1 and BR6 groups compared to the Corn group (p < 0.05), and the activities of α-amylase, trypsin, chymotrypsin and lipase decreased in the BR6 group compared to the BR1 and Corn groups (p < 0.05). Also, compared to the BR1 group, the overall expression of metabolites involved in drug metabolism—cytochrome P450, GnRH secretion and the estrogen signaling pathway in broiler ileum were down-regulated in the BR6 group (p < 0.05). In conclusion, the lipid oxidation of stored brown rice decreased digestive enzyme activities and changed metabolic characteristics in the ileum of broilers. While replacing corn with brown rice did not affect broiler growth performance, it reduced the contents of unsaturated and essential fatty acids in breast muscle and enhanced the ileal antioxidant functions of broilers.
- 15 July 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 320 (Pt 3) , 146028
Dietary supplementation of yeast glycoprotein improves egg quality, immunity, antioxidant capacity, and fecal microbiota in laying hen
- 15 July 2025
- Published by Elsevier in International Journal of Biological Macromolecules
- Vol. 320 (Pt 3) , 146028
Dietary supplementation of yeast glycoprotein improves egg quality, immunity, antioxidant capacity, and fecal microbiota in laying hen
- Open Access
- 19 June 2025
- Published by MDPI AG in Preprints.org
The Lipid Oxidation of Stored Brown Rice Changed Ileum Digestive and Metabolic Characteristics in Broiler Chickens
Long-term storage may induce lipid oxidation in brown rice and impact its utilization in animal diet. Broiler chickens were randomly assigned to 3 groups and fed with corn (Corn), fresh (BR1) and stored brown rice (BR6) diet for 42 days, respectively. The results showed that lipid oxidation indexes increased and fatty acid composition changed significantly in stored brown rice. Replacement of corn with fresh or stored brown rice had no effects on growth performance of broilers, however, palmitic acid and oleic acid were increased, stearic acid, linoleic acid and docosadienoic acid were decreased in broiler breast muscle. Ileum antioxidant enzyme activities were increased in BR1 and BR6 groups compared to Corn group, and activities of α-amylase, trypsion, chymotrypsin and lipase were decreased in BR6 group compared to BR1 and Corn groups. Also, compared to BR1 group, the overall expression of different metabolites involved in drug metabolism-cytochrome P450, GnRH secretion and estrogen signaling pathway in broiler ileum were down-regulated in BR6 group. In conclusion, the lipid oxidation of stored brown rice decreased the activity of digestive enzymes and changed metabolic characteristics in ileum of broilers. While replacing corn with brown rice does not affect broiler growth performance, it reduced breast muscle unsaturated and essential fatty acid content and enhanced ileal antioxidant function of broilers.
- 19 June 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Lipid Oxidation of Stored Brown Rice Changed Ileum Digestive and Metabolic Characteristics in Broiler Chickens
Long-term storage may induce lipid oxidation in brown rice and impact its utilization in animal diet. Broiler chickens were randomly assigned to 3 groups and fed with corn (Corn), fresh (BR1) and stored brown rice (BR6) diet for 42 days, respectively. The results showed that lipid oxidation indexes increased and fatty acid composition changed significantly in stored brown rice. Replacement of corn with fresh or stored brown rice had no effects on growth performance of broilers, however, palmitic acid and oleic acid were increased, stearic acid, linoleic acid and docosadienoic acid were decreased in broiler breast muscle. Ileum antioxidant enzyme activities were increased in BR1 and BR6 groups compared to Corn group, and activities of α-amylase, trypsion, chymotrypsin and lipase were decreased in BR6 group compared to BR1 and Corn groups. Also, compared to BR1 group, the overall expression of different metabolites involved in drug metabolism-cytochrome P450, GnRH secretion and estrogen signaling pathway in broiler ileum were down-regulated in BR6 group. In conclusion, the lipid oxidation of stored brown rice decreased the activity of digestive enzymes and changed metabolic characteristics in ileum of broilers. While replacing corn with brown rice does not affect broiler growth performance, it reduced breast muscle unsaturated and essential fatty acid content and enhanced ileal antioxidant function of broilers.
- Open Access
Lactobacillus plantarum 17-1 Ameliorates DSS-Induced Colitis by Modulating the Colonic Microbiota Composition and Metabolome in Mice
Background/Objectives: Lactobacillus strains are widely used as probiotics in the functional food industry and show potential for treating inflammatory bowel disease (IBD). However, the strain specificity and limited stress resistance of Lactobacillus restricts its therapeutic effectiveness. The aim of this study was to investigate the effects of dietary supplementation with microencapsulated Lactobacillus plantarum 17-1 on the intestinal immune responses, gut microbiota composition, and metabolic characteristics in colitis mice. Methods: Mice were pre-fed a diet containing microencapsulated Lactobacillus plantarum 17-1 for 3 weeks and then treated with 2.5% dextran sulfate sodium (DSS) in drinking water for 8 days to induce colitis. Results: The results showed that microencapsulated Lactobacillus plantarum 17-1 effectively alleviated clinical symptoms and histopathological features of colitis mice and suppressed the up-regulation of pro-inflammatory cytokines IL-6 and IL-17 in the colon of colitis mice. Additionally, Lactobacillus plantarum 17-1 significantly increased the relative abundance of several beneficial bacterial taxa, including Ruminococcaceae_UCG_014, Bacteroides, Prevotellaceae_UCG_001, Lactococcus, Weissella, Pediococcus, and so on. Moreover, it regulated the levels of multiple inflammation-related metabolites involved in linolenic acid metabolism, arachidonic acid metabolism, primary bile acid biosynthesis, and tyrosine metabolism. Conclusions: These results suggest that dietary supplementation with microencapsulated Lactobacillus plantarum 17-1 reduced colitis inflammation in mice by modulating the intestinal microbiota composition and metabolic characteristics, which may serve as a potential therapeutic strategy for IBD.
Open AccessLactobacillus plantarum 17-1 Ameliorates DSS-Induced Colitis by Modulating the Colonic Microbiota Composition and Metabolome in Mice
Background/Objectives: Lactobacillus strains are widely used as probiotics in the functional food industry and show potential for treating inflammatory bowel disease (IBD). However, the strain specificity and limited stress resistance of Lactobacillus restricts its therapeutic effectiveness. The aim of this study was to investigate the effects of dietary supplementation with microencapsulated Lactobacillus plantarum 17-1 on the intestinal immune responses, gut microbiota composition, and metabolic characteristics in colitis mice. Methods: Mice were pre-fed a diet containing microencapsulated Lactobacillus plantarum 17-1 for 3 weeks and then treated with 2.5% dextran sulfate sodium (DSS) in drinking water for 8 days to induce colitis. Results: The results showed that microencapsulated Lactobacillus plantarum 17-1 effectively alleviated clinical symptoms and histopathological features of colitis mice and suppressed the up-regulation of pro-inflammatory cytokines IL-6 and IL-17 in the colon of colitis mice. Additionally, Lactobacillus plantarum 17-1 significantly increased the relative abundance of several beneficial bacterial taxa, including Ruminococcaceae_UCG_014, Bacteroides, Prevotellaceae_UCG_001, Lactococcus, Weissella, Pediococcus, and so on. Moreover, it regulated the levels of multiple inflammation-related metabolites involved in linolenic acid metabolism, arachidonic acid metabolism, primary bile acid biosynthesis, and tyrosine metabolism. Conclusions: These results suggest that dietary supplementation with microencapsulated Lactobacillus plantarum 17-1 reduced colitis inflammation in mice by modulating the intestinal microbiota composition and metabolic characteristics, which may serve as a potential therapeutic strategy for IBD.
- Open Access
- 13 March 2025
- Published by MDPI AG in Preprints.org
Lactobacillus plantarum 17‐1 Ameliorate DSSInduced Colitis by Modulating Colonic Microbiota Composition and Metabolome in Mice
Background/Objectives: Lactobacillus strains are widely used as probiotics in the functional food industry and show potential for treating inflammatory bowel disease (IBD). The aim of this study was to investigate the effects of dietary supplementation with microencapsulated Lactobacillus plantarum 17-1 on the intestinal immune response and gut microbiota in mice with colitis. Methods: Mice were pre-fed a diet containing microencapsulated Lactobacillus plantarum 17-1 for three weeks, followed by colitis induction using 2.5% dextran sulfate sodium (DSS) in drinking water for 8 days. Results: Lactobacillus plantarum 17-1 significantly improved clinical symptoms and histopathological features in colitis-affected mice. Additionally, it effectively suppressed the up-regulation of pro-inflammatory cytokines IL-6 and IL-17 in the colon tissue of the mice. The probiotic administration increased the linear discriminant analysis score for several beneficial bacterial taxa, including Ruminococcaceae_UCG_014, Bacteroides, Prevotellaceae_UCG_001, Lactococcus, Weissella, Pediococcus, and so on. Also, Lactobacillus plantarum 17-1 regulated the abundance of inflammation-related metabolites which involved in linolenic acid metabolism, arachidonic acid metabolism, primary bile acid biosynthesis and tyrosine metabolism. Conclusions: These findings indicate that microencapsulated Lactobacillus plantarum 17-1 has a significant anti-inflammatory effect in the DSS-induced colitis model and may serve as a potential therapeutic strategy for IBD.
- 13 March 2025
- Published by MDPI AG in Preprints.org
Open AccessLactobacillus plantarum 17‐1 Ameliorate DSSInduced Colitis by Modulating Colonic Microbiota Composition and Metabolome in Mice
Background/Objectives: Lactobacillus strains are widely used as probiotics in the functional food industry and show potential for treating inflammatory bowel disease (IBD). The aim of this study was to investigate the effects of dietary supplementation with microencapsulated Lactobacillus plantarum 17-1 on the intestinal immune response and gut microbiota in mice with colitis. Methods: Mice were pre-fed a diet containing microencapsulated Lactobacillus plantarum 17-1 for three weeks, followed by colitis induction using 2.5% dextran sulfate sodium (DSS) in drinking water for 8 days. Results: Lactobacillus plantarum 17-1 significantly improved clinical symptoms and histopathological features in colitis-affected mice. Additionally, it effectively suppressed the up-regulation of pro-inflammatory cytokines IL-6 and IL-17 in the colon tissue of the mice. The probiotic administration increased the linear discriminant analysis score for several beneficial bacterial taxa, including Ruminococcaceae_UCG_014, Bacteroides, Prevotellaceae_UCG_001, Lactococcus, Weissella, Pediococcus, and so on. Also, Lactobacillus plantarum 17-1 regulated the abundance of inflammation-related metabolites which involved in linolenic acid metabolism, arachidonic acid metabolism, primary bile acid biosynthesis and tyrosine metabolism. Conclusions: These findings indicate that microencapsulated Lactobacillus plantarum 17-1 has a significant anti-inflammatory effect in the DSS-induced colitis model and may serve as a potential therapeutic strategy for IBD.
- Open Access
- 8 March 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-18
Probiotic nanocomposite materials with excellent resistance, inflammatory targeting, and multiple efficacies for enhanced treatment of colitis in mice
The occurrence of inflammatory bowel disease (IBD) is relevant to impaired intestinal mucosal barrier and disordered gut microbiota, subsequently leading to excessive production of reactive oxygen species (ROS) and elevated levels of inflammatory factors. Traditional therapies focus on inhibiting inflammation, but the vast majority involve non-targeted systemic administration, whose long-term use may result in potential side effects. Oral microbial therapy has exhibited great application prospects currently in IBD treatment; however, its progress has been slowed by issues with deficient bioavailability, poor targeting of colitis, and low therapeutic efficacy. Consequently, it is exceedingly desirable to develop a strategy by which probiotics can be endowed with additional anti-inflammatory and antioxidant properties, as well as enhanced targeting of the inflamed intestine. Herein, we present an innovative therapeutic strategy for encapsulating probiotic Bacillus coagulans spores with rosmarinic acid (RA) and silk fibroin (SF). Probiotics in spore morphology possessed strong gastrointestinal environmental resistance; RA alleviated oxidative damage by scavenging ROS and inhibited inflammatory responses; SF assisted probiotics release and colonize in the inflamed intestine. We demonstrated the therapeutic efficacy of probiotic composite materials in a colitis mouse model, which significantly alleviated a series of colitis symptoms, inhibited inflammatory cytokine storms, restored the balance of the gut microbiota, and downregulated inflammation-related signaling pathways. We are optimistic that the utilization of therapeutic nanocoating to modify probiotics will open up novel avenues for future microbial therapy targeting IBD.
- 8 March 2025
- Published by Springer Nature in Journal of Nanobiotechnology
- Vol. 23 (1) , 1-18
Open AccessProbiotic nanocomposite materials with excellent resistance, inflammatory targeting, and multiple efficacies for enhanced treatment of colitis in mice
The occurrence of inflammatory bowel disease (IBD) is relevant to impaired intestinal mucosal barrier and disordered gut microbiota, subsequently leading to excessive production of reactive oxygen species (ROS) and elevated levels of inflammatory factors. Traditional therapies focus on inhibiting inflammation, but the vast majority involve non-targeted systemic administration, whose long-term use may result in potential side effects. Oral microbial therapy has exhibited great application prospects currently in IBD treatment; however, its progress has been slowed by issues with deficient bioavailability, poor targeting of colitis, and low therapeutic efficacy. Consequently, it is exceedingly desirable to develop a strategy by which probiotics can be endowed with additional anti-inflammatory and antioxidant properties, as well as enhanced targeting of the inflamed intestine. Herein, we present an innovative therapeutic strategy for encapsulating probiotic Bacillus coagulans spores with rosmarinic acid (RA) and silk fibroin (SF). Probiotics in spore morphology possessed strong gastrointestinal environmental resistance; RA alleviated oxidative damage by scavenging ROS and inhibited inflammatory responses; SF assisted probiotics release and colonize in the inflamed intestine. We demonstrated the therapeutic efficacy of probiotic composite materials in a colitis mouse model, which significantly alleviated a series of colitis symptoms, inhibited inflammatory cytokine storms, restored the balance of the gut microbiota, and downregulated inflammation-related signaling pathways. We are optimistic that the utilization of therapeutic nanocoating to modify probiotics will open up novel avenues for future microbial therapy targeting IBD.